LAZLazard, Inc.
Is the price fair?
At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Expensive vs its own history: P/E 14.5 vs a 9.1 median over 36 quarters (+59% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What LAZ's price assumes
Lazard, Inc. trades at 14.5× earnings against 19.0× for the median Capital Markets name, cheaper than its own group.
Trailing P/E · Capital Markets median 19.0 · cheaper than the typical name in its group
- Price / sales
- 1.36
Price / sales · as of 2026-Q1
- Price / book
- 5.09
Price / book · as of 2026-Q1
- EV / sales
- 1.56
EV / sales
Details›
- Price / bookas of 2026-Q1
- 5.09
- EV / EBITas of 2026-Q1
- 14.2
- EV / salesas of 2026-Q1
- 1.56
- Financial Services median P/E625 names
- 12.1
- Capital Markets median P/E49 names
- 19.0
- Market capitalisation
- $4.00B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $20.10 |
| Its own P/E history, median | $23.08 |
| Its own P/E history, upper quartile | $37.03 |
| 52-week range | $35.30 – $56.41 |
| Today | $36.77 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Capital Markets
The closest names by size in the same industry